Accelerated approval: unfulfilled promises for FDA’s expedited review program

The Hill

27 May 2022 - As practicing physicians, approval by the U.S. FDA reassures us that the treatments we prescribe our patients have been rigorously vetted as effective and safe. 

For a growing number of drugs, however, FDA approval comes with lingering uncertainty of their benefit.

Read The Hill article

Michael Wonder

Posted by:

Michael Wonder